Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Selected Reading
Ghosh S, Karin M. Missing pieces in the NF-κB puzzle. Cell 2002;109(Suppl):S81–S96. (This review paper discusses the NF-κB signaling pathways, their regulation and the IKK complexes in further detail.)
Wang H, Czura CJ, Tracey KJ. Tumor necrosis factor. In: Thomson AW, Lotze MT, eds. The Cytokine Handbook, vol II (4th ed). Amsterdam: Academic Press, 2003:837–860. (This book chapter provides a comprehensive discussion of the effects of TNF signaling in both hepatic and extrahepatic tissues.)
Suryprasad AG, Prindiville T. The biology of TNF blockade. Autoimmunity Reviews 2003;2:346–357. (This paper reviews the methods of anti-TNF therapy in autoimmune and chronic inflammatory diseases.)
Maeda S, Chang L, Li Z-W et al. IKKβ is required for prevention of apoptosis mediated by cell-bound but not circulating TNFα. Immunity 2003;19:725–737. (This is an original research paper that details the effects of hepatocyte-specific IKKβ ablation on liver injury from TNF.)
Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003;3:745–756.
Akerman P, Cote P, Yang SQ et al. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992;263:G579–G585.
Akerman PA, Cote PM, Yang SQ et al. Long-term ethanol consumption alters the hepatic response to the regenerative effects of tumor necrosis factor-alpha. Hepatology 1993;17:1066–1073.
Alcamo E, Mizgerd JP, Horwitz BH et al. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J Immunol 2001;167:1592–1600.
Amour A, Slocombe PM, Webster A et al. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998;435:39–44.
Arvelo MB, Cooper JT, Longo C et al. A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 2002;35:535–543.
Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999;11:255–260.
Bai J, Cederbaum AI. Overexpression of catalase in the mitochondrial or cytosolic compartment increases sensitivity of HepG2 cells to tumor necrosis factor-alpha-induced apoptosis. J Biol Chem 2000;275:19241–19249.
Banner DW, D’Arcy A, Janes W et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 1993;73:431–445.
Barbara JA, Smith WB, Gamble JR et al. Dissociation of TNF-alpha cytotoxic and proinflammatory activities by p55 receptor-and p75 receptor-selective TNF-alpha mutants. EMBO J 1994;13:843–850.
Barnhart BC, Alappat EC, Peter ME. The CD95 type I/type II model. Semin Immunol 2003;15:185–193.
Beg AA, Sha WC, Bronson RT et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995;376:167–170.
Bhardwaj A, Aggarwal BB. Receptor-mediated choreography of life and death. J Clin Immunol 2003;23:317–332.
Biermer M, Puro R, Schneider RJ. Tumor necrosis factoralpha inhibition of hepatitis B virus replication involves disruption of capsid integrity through activation of NF-kappaB. J Virol 2003;77:4033–4042.
Black RA, Rauch CT, Kozlosky CJ et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997;385:729–733.
Blindenbacher A, Wang X, Langer I et al. Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology 2003;38:674–682.
Bradham CA, Qian T, Streetz K et al. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol 1998;18:6353–6364.
Chaisson ML, Brooling JT, Ladiges W et al. Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest 2002;110:193–202.
Chan FK, Chun HJ, Zheng L et al. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 2000;288:2351–2354.
Chinnaiyan AM, O’Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505–512.
Chinnaiyan AM, Tepper CG, Seldin MF et al. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 1996;271:4961–4965.
Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000;232:155–162.
Colletti LM, Kunkel SL, Walz A et al. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 1996;23:506–514.
Cressman DE, Greenbaum LE, DeAngelis RA et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379–1383.
Czaja MJ. The future of GI and liver research: editorial perspectives. III. JNK/AP-1 regulation of hepatocyte death. Am J Physiol Gastrointest Liver Physiol 2003;284:G875–G879.
Czaja MJ, Flanders KC, Biempica L et al. Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in acute liver injury. Growth Factors 1989;1:219–226.
Czaja MJ, Schilsky ML, Xu Y et al. Induction of MnSOD gene expression in a hepatic model of TNF-alpha toxicity does not result in increased protein. Am J Physiol 1994;266:G737–G744.
Czaja MJ, Xu J, Alt E. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 1995;108:1849–1854.
de la Coste A, Fabre M, McDonell N et al. Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice. Am J Physiol 1999;277:G702–G708.
De Smaele E, Zazzeroni F, Papa S et al. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 2001;414:308–313.
DeAngelis RA, Kovalovich K, Cressman DE, Taub R. Normal liver regeneration in p50/nuclear factor kappaB1 knockout mice. Hepatology 2001;33:915–924.
Deng Y, Ren X, Yang L et al. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 2003;115:61–70.
Devin A, Cook A, Lin Y et al. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKKto TNF-R1 while RIP mediates IKK activation. Immunity 2000;12:419–429.
Devin A, Lin Y, Yamaoka S et al. The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. Mol Cell Biol 2001;21:3986–3994.
Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999;68:383–424.
Fotin-Mleczek M, Henkler F, Samel D et al. Apoptotic crosstalk of TNF receptors: TNF-R2 induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J Cell Sci 2002;115:2757–2770.
Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002;109(Suppl):S81–S96.
Grell M, Douni E, Wajant H et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995;83:793–802.
Grell M, Wajant H, Zimmermann G, Scheurich P. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. PNAS 1998;95:570–575.
Guicciardi ME, Deussing J, Miyoshi H et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000;106:1127–1137.
Haouzi D, Lekehal M, Tinel M et al. Prolonged, but not acute, glutathione depletion promotes Fas-mediated mitochondrial permeability transition and apoptosis in mice. Hepatology 2001;33:1181–1188.
Harper N, Hughes M, MacFarlane M, Cohen GM. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. J Biol Chem 2003;278:25534–25541.
Hatano E, Bennett BL, Manning AM et al. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha-and Fas-mediated apoptosis. Gastroenterology 2001;120:1251–1262.
Hatano E, Brenner DA. Akt protects mouse hepatocytes from TNF-alpha-and Fas-mediated apoptosis through NK-kappa B activation. Am J Physiol Gastrointest Liver Physiol 2001;281:G1357–G1368.
Hehlgans T, Seitz C, Lewis C, Mannel DN. Hypoxic upregulation of TNF receptor type 2 expression involves NF-IL-6 and is independent of HIF-1 or HIF-2. J Interferon Cytokine Res 2001;21:757–762.
Honchel R, Marsano L, Cohen D et al. Lead enhances lipopolysaccharide and tumor necrosis factor liver injury. J Lab Clin Med 1991;117:202–208.
Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996;84:299–308.
Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995;81:495–504.
Iimuro Y, Nishiura T, Hellerbrand C et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 1998;101:802–811.
Jaeschke H, Farhood A, Cai SX et al. Protection against TNF-induced liver parenchymal cell apoptosis during endotoxemia by a novel caspase inhibitor in mice. Toxicol Appl Pharmacol 2000;169:77–83.
Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003;125:1246–1257.
Jiang Y, Woronicz JD, Liu W, Goeddel DV. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 1999;283:543–546.
Jones BE, Lo CR, Liu H et al. Hepatocytes sensitized to tumor necrosis factor-alpha cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways. J Biol Chem 2000;275:705–712.
Juo P, Kuo CJ, Yuan J, Blenis J. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 1998;8:1001–1008.
Kern PA, Ranganathan S, Li C et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001;280:E745–E751.
Khoruts A, Stahnke L, McClain CJ et al. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991;13:267–276.
Kim KH, Seong BL. Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal. EMBO J 2003;22:2104–2116.
Kischkel FC, Hellbardt S, Behrmann I et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995;14:5579–5588.
Koteish A, Yang S, Lin H et al. Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation. J Biol Chem 2002;277:13037–13044.
Kunstle G, Hentze H, Germann PG et al. Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation. Hepatology 1999;30:1241–1251.
Lee TH, Huang Q, Oikemus S et al. The death domain kinase RIP1 is essential for tumor necrosis factor alpha signaling to p38 mitogen-activated protein kinase. Mol Cell Biol 2003;23:8377–8385.
Legler DF, Micheau O, Doucey MA et al. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 2003;18:655–664.
Leist M, Gantner F, Bohlinger I et al. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol 1994;153:1778–1788.
Leitges M, Sanz L, Martin P et al. Targeted disruption of the zeta PKC gene results in the impairment of the NF-kappaB pathway. Mol Cell 2001;8:771–780.
Li J, Bombeck CA, Yang S et al. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J Biol Chem 1999;274:17325–17333.
Li W, Liang X, Kellendonk C et al. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 2002;277:28411–28417.
Liedtke C, Plumpe J, Kubicka S et al. Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells. Hepatology 2002;36:315–325.
Liu H, Jones BE, Bradham C, Czaja MJ. Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF-alpha. Am J Physiol Gastrointest Liver Physiol 2002;282:G257–G266.
Liu H, Lo CR, Czaja MJ. NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology 2002;35:772–778.
Loffreda S, Rai R, Yang SQ et al. Bile ducts and portal and central veins are major producers of tumor necrosis factor alpha in regenerating rat liver. Gastroenterology 1997;112:2089–2098.
Maeda S, Chang L, Li ZW et al. IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha. Immunity 2003;19:725–737.
Marusawa H, Hijikata M, Chiba T, Shimotohno K. Hepatitis C virus core protein inhibits Fas-and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol 1999;73:4713–4720.
McClary H, Koch R, Chisari FV, Guidotti LG. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol 2000;74:2255–2264.
Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003;114:181–190.
Moorthy AK, Ghosh G. p105-Ikappa Bgamma and prototypical Ikappa Bs usea similar mechanism to bind but a different mechanism to regulate the subcellular localization of NF-kappa B. J Biol Chem 2003;278:556–566.
Morio LA, Chiu H, Sprowles KA et al. Distinct roles of tumor necrosis factor-alpha and nitric oxide in acute liver injury induced by carbon tetrachloride in mice. Toxicol Appl Pharmacol 2001;172:44–51.
Moss ML, Lambert MH. Shedding of membrane proteins by ADAM family proteases. Essays Biochem 2002;38:141–153.
Muzio M, Stockwell BR, Stennicke HR et al. An induced proximity model for caspase-8 activation. J Biol Chem 1998;273:2926–2930.
Neumann M, Grieshammer T, Chuvpilo S et al. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J 1995;14:1991–2004.
Oliver FJ, Menissier-de Murcia J, Nacci C et al. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 1999;18:4446–4454.
Osawa Y, Banno Y, Nagaki M et al. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J Immunol 2001;167:173–180.
Park YC, Burkitt V, Villa AR et al. Structural basis for self-association and receptor recognition of human TRAF2. Nature 1999;398:533–538.
Park YC, Ye H, Hsia C et al. A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell 2000;101:777–787.
Perkins ND. The Rel/NF-kappa B family: friend and foe. Trends Biochem Sci 2000;25:434–440.
Peschon JJ, Slack JL, Reddy P et al. An essential role for ectodomain shedding in mammalian development. Science 1998;282:1281–1284.
Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 2003;10:26–35.
Rai RM, Lee FY, Rosen A et al. Impaired liver regeneration in inducible nitric oxide synthase deficient mice. Proc Natl Acad Sci USA 1998;95:13829–13834.
Rudiger HA, Clavien PA. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 2002;122:202–210.
Sakamoto T, Liu Z, Murase N et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 1999;29:403–411.
Scaffidi C, Fulda S, Srinivasan A et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998;17:1675–1687.
Schwabe RF, Bennett BL, Manning AM, Brenner DA. Differential role of I kappa B kinase 1 and 2 in primary rat hepatocytes. Hepatology 2001;33:81–90.
Schwabe RF, Bradham CA, Uehara T et al. c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 2003;37:824–832.
Solan NJ, Miyoshi H, Carmona EM et al. RelB cellular regulation and transcriptional activity are regulated by p100. J Biol Chem 2002;277:1405–1418.
Streetz K, Leifeld L, Grundmann D et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 2000;119:446–460.
Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing bytumor necrosis factor alpha. Proc Natl Acad Sci USA 1997;94:8744–8749.
Su F, Theodosis CN, Schneider RJ. Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol 2001;75:215–225.
Tada K, Okazaki T, Sakon S et al. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. J Biol Chem 2001;276:36530–36534.
Tartaglia LA, Pennica D, Goeddel DV. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 1993;268:18542–18548.
Teoh N, Leclercq I, Pena AD, Farrell G. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 2003;37:118–128.
Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312–1316.
Tibbetts MD, Zheng L, Lenardo MJ. The death effector domain protein family: regulators of cellular homeostasis. Nat Immunol 2003;4:404–409.
Togashi H, Ohno S, Matsuo T et al. Interferon-gamma, tumor necrosis factor-alpha, and interleukin 1-beta suppress the replication of hepatitis B virus through oxidative stress. Res Commun Mol Pathol Pharmacol 2000;107:407–417.
Tournier C, Dong C, Turner TK et al. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev 2001;15:1419–1426.
Van Molle W, Denecker G, Rodriguez I et al. Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. J Immunol 1999;163:5235–5241.
Vandenabeele P, Declercq R, Beyaert W, Fiers W. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol 1988;5:392–399.
Volpes R, van den Oord JJ, De Vos R, Desmet VJ. Hepatic expression of type A and type B receptors for tumor necrosis factor. J Hepatol 1992;14:361–369.
Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003;10:45–65.
Wang D, Westerheide SD, Hanson JL, Baldwin AS, Jr. Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J Biol Chem 2000;275:32592–32597.
Wei MC, Zong WX, Cheng EH et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001;292:727–730.
Werneburg NW, Guicciardi ME, Bronk SF, Gores GJ. Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent. Am J Physiol Gastrointest Liver Physiol 2002;283:G947–G956.
Wuestefeld T, Klein C, Streetz KL et al. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 2003;278:11281–11288.
Xu Y, Bialik S, Jones BE et al. NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis. Am J Physiol 1998;275:C1058–C1066.
Xu Y, Jones BE, Neufeld DS, Czaja MJ. Glutathione modulates rat and mouse hepatocyte sensitivity to tumor necrosis factor toxicity. Gastroenterology 1998;115:1229–1237.
Yadav SS, Howell DN, Gao W et al. L-selectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischemic mouse liver. Am J Physiol 1998;275:G1341–G1352.
Yamada Y, Fausto N. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factorreceptor. Am J Pathol 1998;152:1577–1589.
Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997;94:1441–1446.
Yamada Y, Webber EM, Kirillova I et al. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology 1998;28:959–970.
Yang SQ, Lin HZ, Yin M et al. Effects of chronic ethanol consumption on cytokine regulation of liver regeneration. Am J Physiol 1998;275:G696–G704.
Yared G, Hussain KB, Nathani MG et al. Cytokine-mediated apoptosis and inhibition of virus production and anchorage independent growth of viral transfected hepatoblastoma cells. Cytokine 1998;10:586–595.
Yeh WC, Itie A, Elia AJ et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 2000;12:633–642.
Yeh WC, Shahinian A, Speiser D et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997;7:715–725.
Yin M, Wheeler MD, Kono H et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999;117:942–952.
Young CS, Palma JM, Mosher BD et al. Hepatic ischemia/reperfusion injury in P-selectin and intercellular adhesion molecule-1 double-mutant mice. Am Surg 2001;67:737–744.
Zhao Y, Ding WX, Qian T et al. Bid activates multiple mitochondrial apoptotic mechanisms in primary hepatocytes after death receptor engagement. Gastroenterology 2003;125:854–867.
Zhao Y, Li S, Childs EE et al. Activation of pro-death Bcl-2 family proteins and mitochondria apoptosis pathway in tumor necrosis factor-alpha-induced liver injury. J Biol Chem 2001;276:27432–27440.
Zhu N, Khoshnan A, Schneider R et al. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 1998;72:3691–3697.
Zou H, Li Y, Liu X, Wang X. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999;274:11549–11556.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schattenberg, J.M., Czaja, M.J. (2005). Nature and Function of Hepatic Tumor Necrosis Factor-α Signaling. In: Dufour, JF., Clavien, PA., Trautwein, C., Graf, R. (eds) Signaling Pathways in Liver Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27194-5_10
Download citation
DOI: https://doi.org/10.1007/3-540-27194-5_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22934-6
Online ISBN: 978-3-540-27194-9
eBook Packages: MedicineMedicine (R0)